Lian‐Wen Qi

机构：Shenyang Pharmaceutical University, Nanjing University of Chinese Medicine, Chongqing University, China Pharmaceutical University · ORCID：0000-0003-0728-4475

发表论文 277 篇 · 总被引 12971 次 · h-index 65

代表论文

• Ceramides increase mitochondrial permeabilization to trigger mtDNA-dependent inflammation in astrocytes during brain ischemia (2025 · Metabolism · 被引 40)
• Bifunctional LYTAC Mediates Hepatocytes-Hepatic Stellate Cells Crosstalk by Regulating 5-HT 2A Receptor Degradation and Antagonism to Synergistically Ameliorate Hepatic Fibrosis (2025 · Journal of the American Chemical Society · 被引 8)
• Xinkeshu formula restrains pathological cardiac hypertrophy through metabolic remodeling via AMPK/mTOR pathway (2024 · Phytomedicine · 被引 6)
• CPS1 augments hepatic glucagon response through CaMKII/FOXO1 pathway (2024 · Frontiers in Pharmacology · 被引 4)
• The potential therapeutic role of ginsenosides on fibrosis-associated diseases: a review on molecular mechanisms and call for further research (2025 · Chinese Journal of Natural Medicines · 被引 3)
• Endothelial neuraminidase 1 inhibition attenuates LPS-induced acute lung injury through the CXCR4 pathway (2025 · Glycoscience & Therapy · 被引 2)